ID

29193

Beschreibung

A Study of Insulin Lispro Mix in Type 2 Diabetic Asian Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00971997

Link

https://clinicaltrials.gov/show/NCT00971997

Stichworte

  1. 06.03.18 06.03.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

6. März 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes Mellitus, Type 2 NCT00971997

Eligibility Diabetes Mellitus, Type 2 NCT00971997

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients diagnosed as having type 2 diabetes.
Beschreibung

Diabetes Mellitus, Non-Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
patients who have not been on insulin treatment within 6 months.
Beschreibung

Insulin regime Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0557978
UMLS CUI [1,2]
C0332197
patients who have been taking oads for at least 90 days.
Beschreibung

Antidiabetics Oral

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
patients with an hba1c level in the range of 7.5% to 11.0%.
Beschreibung

Glucohemoglobin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0202054
patients with a body-mass index (bmi) of 35 kg/m² or below.
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients having pre-proliferative or proliferative retinopathy (except for old retinopathy with no need for treatment).
Beschreibung

Preproliferative diabetic retinopathy | Proliferative retinopathy | Exception Retinal Disease No treatment required for

Datentyp

boolean

Alias
UMLS CUI [1]
C0339473
UMLS CUI [2]
C0339467
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0035309
UMLS CUI [3,3]
C0332126
patients having or suspected of having malignancy
Beschreibung

Malignant Neoplasms | Malignant Neoplasms Suspected

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0750491
patients having serious complications of the heart, liver, or kidney.
Beschreibung

Cardiac complication Serious | Hepatic complications Serious | Kidney complications Serious

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0161816
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C1832055
UMLS CUI [2,2]
C0205404
UMLS CUI [3,1]
C1408259
UMLS CUI [3,2]
C0205404
patients hypersensitive or allergic to insulin or insulin analog preparations or a history of it.
Beschreibung

Insulin allergy | Hypersensitivity Insulin Analog

Datentyp

boolean

Alias
UMLS CUI [1]
C0571622
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C2825028
patients receiving systemic steroids.
Beschreibung

Systemic steroids

Datentyp

boolean

Alias
UMLS CUI [1]
C2825233
are currently enrolled in a clinical trial of a non-approved drug. or patients who participated in other clinical trials including post-marketing clinical trials within 90 days prior to informed consent being obtained.
Beschreibung

Study Subject Participation Status | Drugs, Non-Prescription | Post marketing study

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013231
UMLS CUI [3]
C1548594
patients of child-bearing potential. breastfeeding patients. patients with a positive result in a pregnancy test performed for women of child-bearing potential.
Beschreibung

Childbearing Potential | Breast Feeding | Childbearing Potential Pregnancy test positive

Datentyp

boolean

Alias
UMLS CUI [1]
C3831118
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0240802

Ähnliche Modelle

Eligibility Diabetes Mellitus, Type 2 NCT00971997

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
patients diagnosed as having type 2 diabetes.
boolean
C0011860 (UMLS CUI [1])
Insulin regime Absent
Item
patients who have not been on insulin treatment within 6 months.
boolean
C0557978 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Antidiabetics Oral
Item
patients who have been taking oads for at least 90 days.
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
Glucohemoglobin measurement
Item
patients with an hba1c level in the range of 7.5% to 11.0%.
boolean
C0202054 (UMLS CUI [1])
Body mass index
Item
patients with a body-mass index (bmi) of 35 kg/m² or below.
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Preproliferative diabetic retinopathy | Proliferative retinopathy | Exception Retinal Disease No treatment required for
Item
patients having pre-proliferative or proliferative retinopathy (except for old retinopathy with no need for treatment).
boolean
C0339473 (UMLS CUI [1])
C0339467 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0035309 (UMLS CUI [3,2])
C0332126 (UMLS CUI [3,3])
Malignant Neoplasms | Malignant Neoplasms Suspected
Item
patients having or suspected of having malignancy
boolean
C0006826 (UMLS CUI [1])
C0006826 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
Cardiac complication Serious | Hepatic complications Serious | Kidney complications Serious
Item
patients having serious complications of the heart, liver, or kidney.
boolean
C0161816 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C1832055 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C1408259 (UMLS CUI [3,1])
C0205404 (UMLS CUI [3,2])
Insulin allergy | Hypersensitivity Insulin Analog
Item
patients hypersensitive or allergic to insulin or insulin analog preparations or a history of it.
boolean
C0571622 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C2825028 (UMLS CUI [2,2])
Systemic steroids
Item
patients receiving systemic steroids.
boolean
C2825233 (UMLS CUI [1])
Study Subject Participation Status | Drugs, Non-Prescription | Post marketing study
Item
are currently enrolled in a clinical trial of a non-approved drug. or patients who participated in other clinical trials including post-marketing clinical trials within 90 days prior to informed consent being obtained.
boolean
C2348568 (UMLS CUI [1])
C0013231 (UMLS CUI [2])
C1548594 (UMLS CUI [3])
Childbearing Potential | Breast Feeding | Childbearing Potential Pregnancy test positive
Item
patients of child-bearing potential. breastfeeding patients. patients with a positive result in a pregnancy test performed for women of child-bearing potential.
boolean
C3831118 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0240802 (UMLS CUI [3,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video